In this study, we confirmed the prognostic significance of integrating CLDN6 with ferroptosis, and elucidated a novel mechanism by which CLDN6 triggers NRF2-mediated ferroptosis in breast cancer. Here, CLDN6 is linked to breast carcinoma.